Archive for November 2023
Whoop acquires Boston AI startup, adds to leadership team
This deal fits in with Whoop’s recent moves to invest in its new conversational digital fitness coach. Read More
Read MoreLab slump hits Somerville just as big projects near completion
One year ago almost to the day, the family who owns the Nissenbaum’s Auto Parts junkyard in Somerville was on the brink of becoming $150 million richer. Things did not go as planned. Read More
Read MoreLawmakers reach accord on supplemental budget with $50M for overflow shelter
Senate Democrats are now on board with a House plan to require the Healey administration to stand up an overflow site for shelter-eligible families stuck on a waitlist, but a lack of apparent Republican support may slow the advancement of a compromise. Read More
Read MoreHow a BC grad’s nonprofit landed a $137 million donation
A Boston College graduate who started a malnutrition nonprofit in 2009 has landed a grant that’ll allow it to double capacity and address a stubborn worldwide problem. Read More
Read MoreCitizens continues to close Stop & Shop branches, replaces with ITMs
In November, more bank branches closed than opened in Massachusetts, returning to a trend of widespread closures after October’s outlier month of more openings. Read More
Read MoreDesktop Metal warned to raise stock price or face delisting
The 3D-printing company is the third Bay State tech company in two months to receive the delisting warning notice from a major exchange. Read More
Read MoreCOO of Mass General Hospital steps down after 30 years with parent organization
Greg Pauly, the chief operating officer of Massachusetts General Hospital, will step down effective Jan. 31, 2024. Read More
Read MoreNew analysis shows how investors have helped push up Boston housing costs
Investors, who often have the advantage of paying in cash to elbow out the competition, have accounted for a third of purchases in neighborhoods like Chelsea and Lynn in the past two decades, according to a new report. Read More
Read MoreAbbVie to spend $10.1B to acquire ImmunoGen, 43-year-old Waltham biotech
After more than four decades in business, a Waltham drug developer with an ovarian cancer drug will be acquired by a Big Pharma company. Read More
Read MoreFlagship Pioneering is looking to raise $3B for its eighth fund
Flagship Pioneering, the Cambridge venture firm behind Moderna Inc., is looking to raise $3 billion for its eighth fund. Read More
Read More